These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36769022)

  • 41. Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: the role of elastase, complement C4a and interleukin-1beta.
    Nijs J; Van Oosterwijck J; Meeus M; Lambrecht L; Metzger K; Frémont M; Paul L
    J Intern Med; 2010 Apr; 267(4):418-35. PubMed ID: 20433584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neural consequences of post-exertion malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Cook DB; Light AR; Light KC; Broderick G; Shields MR; Dougherty RJ; Meyer JD; VanRiper S; Stegner AJ; Ellingson LD; Vernon SD
    Brain Behav Immun; 2017 May; 62():87-99. PubMed ID: 28216087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Lim EJ; Son CG
    J Transl Med; 2020 Jul; 18(1):289. PubMed ID: 32727489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study.
    Retornaz F; Rebaudet S; Stavris C; Jammes Y
    J Transl Med; 2022 Sep; 20(1):429. PubMed ID: 36153556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The underlying sex differences in neuroendocrine adaptations relevant to Myalgic Encephalomyelitis Chronic Fatigue Syndrome.
    Thomas N; Gurvich C; Huang K; Gooley PR; Armstrong CW
    Front Neuroendocrinol; 2022 Jul; 66():100995. PubMed ID: 35421511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic reprograming in myalgic encephalomyelitis/chronic fatigue syndrome: A narrative of latent viruses.
    Apostolou E; Rosén A
    J Intern Med; 2024 Jul; 296(1):93-115. PubMed ID: 38693641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A scoping review of 'Pacing' for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): lessons learned for the long COVID pandemic.
    Sanal-Hayes NEM; Mclaughlin M; Hayes LD; Mair JL; Ormerod J; Carless D; Hilliard N; Meach R; Ingram J; Sculthorpe NF
    J Transl Med; 2023 Oct; 21(1):720. PubMed ID: 37838675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Role of Autonomic Function in Exercise-induced Endogenous Analgesia: A Case-control Study in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Healthy People.
    Oosterwijck JV; Marusic U; De Wandele I; Paul L; Meeus M; Moorkens G; Lambrecht L; Danneels L; Nijs J
    Pain Physician; 2017 Mar; 20(3):E389-E399. PubMed ID: 28339438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study.
    Giloteaux L; O'Neal A; Castro-Marrero J; Levine SM; Hanson MR
    J Transl Med; 2020 Oct; 18(1):387. PubMed ID: 33046133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential Effects of Exercise on fMRI of the Midbrain Ascending Arousal Network Nuclei in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Gulf War Illness (GWI) in a Model of Postexertional Malaise (PEM).
    Baraniuk JN; Amar A; Pepermitwala H; Washington SD
    Brain Sci; 2022 Jan; 12(1):. PubMed ID: 35053821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Lutz L; Rohrhofer J; Zehetmayer S; Stingl M; Untersmayr E
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Morris G; Maes M
    Med Hypotheses; 2012 Nov; 79(5):607-13. PubMed ID: 22951418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
    Toogood PL; Clauw DJ; Phadke S; Hoffman D
    Pharmacol Res; 2021 Mar; 165():105465. PubMed ID: 33529750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in ME and CFS Symptomology in Patients with Normal and Abnormal Exercise Test Results.
    McManimen SL; Jason LA
    Int J Neurol Neurother; 2017; 4(1):. PubMed ID: 28713856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Rohrhofer J; Hauser L; Lettenmaier L; Lutz L; Koidl L; Gentile SA; Ret D; Stingl M; Untersmayr E
    J Clin Med; 2024 Jan; 13(1):. PubMed ID: 38202282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural killer cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study.
    Querec TD; Lin JS; Chen Y; Helton B; Kogelnik AM; Klimas NG; Peterson DL; Bateman L; Lapp C; Podell RN; Natelson BH; Unger ER;
    J Transl Med; 2023 Apr; 21(1):242. PubMed ID: 37013608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of Post-Exertional Malaise (PEM) in Patients with Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS): A Patient-Driven Survey.
    Holtzman CS; Bhatia S; Cotler J; Jason LA
    Diagnostics (Basel); 2019 Mar; 9(1):. PubMed ID: 30832336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Moneghetti KJ; Skhiri M; Contrepois K; Kobayashi Y; Maecker H; Davis M; Snyder M; Haddad F; Montoya JG
    Sci Rep; 2018 Feb; 8(1):2779. PubMed ID: 29426834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort.
    Legler F; Meyer-Arndt L; Mödl L; Kedor C; Freitag H; Stein E; Hoppmann U; Rust R; Wittke K; Siebert N; Behrens J; Thiel A; Konietschke F; Paul F; Scheibenbogen C; Bellmann-Strobl J
    EClinicalMedicine; 2023 Sep; 63():102146. PubMed ID: 37662515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.